Compare HCA Health Inc (HCA) vs Phillips 66 (PSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Phillips 66 — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Phillips 66 trades at $278.18 (market cap $112.36B). The key difference: Phillips 66 is the larger of the two by market cap, and Phillips 66 pays the higher dividend (1.8%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Phillips 66 for 62 Days on average.
| HCA | PSX | |
|---|---|---|
Market Cap | $96.35B | $112.36B |
Volume | 1,079,453 | 2,374,751 |
Sector | Health | Energy |
52-Week High | $545.13 | $281.60 |
52-Week Low | $361.32 | $126.76 |
Typical Hold Time | 76 Days | 62 Days |
Enterprise Value | $146.88B | $128.83B |
Dividend Yield | 0.7% | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Phillips 66 (PSX) trades at $281.60, up 3.67% over the past 24 hours and near its 52-week high, supported by bullish technical indicators and strong earnings beats in recent quarters. The company's fundamentals show solid profitability with a 4.66% net income margin and 24.02% ROE, while valuation ratios like a P/E of 16.07 and P/S of 0.75 appear reasonable. Recent news highlights structural strength in refining margins and AI-driven operational improvements.
The outlook for PSX is positive, driven by elevated refining crack spreads and debt-reduction progress, but risks include volatile energy prices and potential policy impacts on diesel exports. Analyst consensus leans bullish with a $279 price target, offering moderate upside from current levels amid robust institutional sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →
